Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jacobson-Kram

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Toxicologic Pathology|December 25, 2003
Recommended tissue list for histopathologic examinationAbigail Jacobs, Jeri El Hage, Kenneth Hastings, et al.
Pharmacogenomics|June 24, 2004
Pharmacogenomic data submissions to the FDA: non-clinical case studiesJohn K Leighton, Joseph DeGeorge, David Jacobson-Kram, et al.
Trends in Pharmacological Sciences|December 16, 2017
Modernizing Human Cancer Risk Assessment of TherapeuticsMark R Fielden, Lucas D Ward, Sheroy Minocherhomji, et al.
Toxicologic Pathology|April 24, 2015
Scientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk AssessmentCharles E Wood, Renee R Hukkanen, Radhakrishna Sura, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 24, 2010
ICH guidelines: inception, revision, and implications for drug developmentTao Wang, David Jacobson-Kram, Anne M Pilaro, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 21, 2007
Development of safety qualification thresholds and their use in orally inhaled and nasal drug product evaluationDouglas Ball, James Blanchard, David Jacobson-Kram, et al.
Mutation Research|July 10, 2007
Relevance and follow-up of positive results in in vitro genetic toxicity assays: an ILSI-HESI initiativeVéronique Thybaud, Marilyn Aardema, Daniel Casciano, et al.
Critical Reviews in Toxicology|April 10, 2025
Mode of action approach supports a lack of carcinogenic potential of six organic UV filtersSamuel M Cohen, Alan R Boobis, David Jacobson-Kram, et al.
Regulatory Toxicology and Pharmacology : RTP|November 6, 2020
Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophenGary Eichenbaum, Kyunghee Yang, Yeshitila Gebremichael, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2021
A comprehensive weight of evidence assessment of published acetaminophen genotoxicity data: Implications for its carcinogenic hazard potentialDavid Kirkland, Michael Kovochich, Sharlee L More, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Toxicologic Pathology|December 25, 2003
Recommended tissue list for histopathologic examinationAbigail Jacobs, Jeri El Hage, Kenneth Hastings, et al.
Pharmacogenomics|June 24, 2004
Pharmacogenomic data submissions to the FDA: non-clinical case studiesJohn K Leighton, Joseph DeGeorge, David Jacobson-Kram, et al.
Trends in Pharmacological Sciences|December 16, 2017
Modernizing Human Cancer Risk Assessment of TherapeuticsMark R Fielden, Lucas D Ward, Sheroy Minocherhomji, et al.
Toxicologic Pathology|April 24, 2015
Scientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk AssessmentCharles E Wood, Renee R Hukkanen, Radhakrishna Sura, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 24, 2010
ICH guidelines: inception, revision, and implications for drug developmentTao Wang, David Jacobson-Kram, Anne M Pilaro, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 21, 2007
Development of safety qualification thresholds and their use in orally inhaled and nasal drug product evaluationDouglas Ball, James Blanchard, David Jacobson-Kram, et al.
Mutation Research|July 10, 2007
Relevance and follow-up of positive results in in vitro genetic toxicity assays: an ILSI-HESI initiativeVéronique Thybaud, Marilyn Aardema, Daniel Casciano, et al.
Critical Reviews in Toxicology|April 10, 2025
Mode of action approach supports a lack of carcinogenic potential of six organic UV filtersSamuel M Cohen, Alan R Boobis, David Jacobson-Kram, et al.
Regulatory Toxicology and Pharmacology : RTP|November 6, 2020
Application of the DILIsym® Quantitative Systems Toxicology drug-induced liver injury model to evaluate the carcinogenic hazard potential of acetaminophenGary Eichenbaum, Kyunghee Yang, Yeshitila Gebremichael, et al.
Regulatory Toxicology and Pharmacology : RTP|February 16, 2021
A comprehensive weight of evidence assessment of published acetaminophen genotoxicity data: Implications for its carcinogenic hazard potentialDavid Kirkland, Michael Kovochich, Sharlee L More, et al.
Pageof 4